EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
EKSO on Nasdaq
Shares outstanding
22,522,733
Price per share
$0.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-15,000
Value change
-$4,530
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $1,207,683 +$300,925 2,996,732 +33% Armistice Capital, LLC 31 Mar 2025
Kent Lake PR LLC 4.6% $403,000 1,000,000 Kent Lake PR LLC 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO). This represents 0% of the company’s total 22,522,733 outstanding shares.

Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$4,530 $0.30 0
2025 Q2 15,000 $4,530 -$1,519,000 $0.30 1
2025 Q1 3,785,922 $1,525,045 -$311,397 $0.40 36
2024 Q4 4,039,726 $2,464,077 -$822,166 $0.61 32
2024 Q3 5,345,999 $6,201,410 +$2,781,536 $1.16 27
2024 Q2 1,974,478 $2,083,151 +$330,494 $1.06 26
2024 Q1 1,533,767 $2,085,783 +$379,938 $1.36 33
2023 Q4 1,149,634 $2,873,704 +$155,613 $2.50 33
2023 Q3 1,112,812 $815,357 -$150,114 $0.73 34
2023 Q2 1,317,053 $1,883,008 -$14,711 $1.43 30
2023 Q1 1,324,534 $2,185,143 -$127,129 $1.65 31
2022 Q4 1,433,244 $1,717,408 +$176,343 $1.19 28
2022 Q3 1,273,806 $1,986,246 +$103,903 $1.56 22
2022 Q2 1,203,615 $1,986,261 -$414,866 $1.65 23
2022 Q1 1,437,063 $4,152,457 -$52,029 $2.89 21
2021 Q4 1,463,103 $3,877,743 +$367,947 $2.65 22
2021 Q3 1,270,412 $5,874,294 -$8,757 $4.62 24
2021 Q2 1,271,237 $6,993,594 -$144,279 $5.50 28
2021 Q1 1,284,302 $7,921,728 +$5,989,924 $6.17 28
2020 Q4 312,587 $1,915,662 -$1,993,902 $6.12 14
2020 Q3 1,434,167 $6,801,513 +$1,436,559 $4.75 18
2020 Q2 1,127,771 $9,450,907 +$838,422 $8.40 21
2020 Q1 1,029,843 $2,918,306 +$2,918,306 $2.85 12